Tarsus Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Tarsus Pharmaceuticals Inc.
Ownership: Public
Status: Active
Headquarters country: United States
Ticker symbol: TARS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001819790

Board of directors

Follow this board

Andrew D. Goldberg · Director
Since 2023
Bhaskar Chaudhuri · Director
Since 2023
Bobak R. Azamian · Director · President/CEO and Board Chair
Since 2023
Elizabeth Yeu Lin · Director
Since 2023
Rosemary A. Crane · Director
Since 2023
Scott W. Morrison · Director Overboarded
Since 2023
Wendy L. Yarno · Director
Since 2023
William J. Link Ph.D. · Director
Since 2023

Chief executives

Bobak R. Azamian · President/CEO and Board Chair

Dates unknown

Board connections

6 of this board's directors also sit on 12 other boards.

Shared director Other board Same sector

IDEAYA Biosciences Inc.
via Scott W. Morrison and Wendy L. Yarno
Arcutis Biotherapeutics Inc.
via Bhaskar Chaudhuri
Certara Inc.
via Rosemary A. Crane
Corvus Pharmaceuticals Inc.
via Scott W. Morrison
Inovio Pharmaceuticals Inc.
via Wendy L. Yarno
Iovance Biotherapeutics Inc.
via Wendy L. Yarno
LENSAR Inc.
via William J. Link Ph.D.
RxSight Inc.
via William J. Link Ph.D.
STAAR Surgical Company
via Elizabeth Yeu Lin
Teva Pharmaceutical Industries Limited
via Rosemary A. Crane
Vera Therapeutics Inc.
via Scott W. Morrison
Zai Lab Limited
via Scott W. Morrison

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Dec 27, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−8,000	$20.22	$161,760
Dec 20, 2023	Trevejo Jose M. Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−2,252	$20.00	$45,040
Dec 20, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−9,443	$19.96	$188,482
Dec 20, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−30,557	$20.36	$622,141
Dec 15, 2023	Andrew D. Goldberg Director	Open-market purchase	+1,000	$18.96	$18,960
Dec 2, 2023	Wendy L. Yarno Director	Option exercise	+5,000	—	—
Nov 30, 2023	Whitfield Dianne C. Officer (Chief Human Resources Officer)	Open-market sale	−8,355	$16.31	$136,270
Nov 30, 2023	Wahl Bryan Officer (General Counsel)	Open-market sale	−8,356	$16.31	$136,286
Nov 29, 2023	Whitfield Dianne C. Officer (Chief Human Resources Officer)	Option exercise	+23,920	—	—
Nov 29, 2023	Wahl Bryan Officer (General Counsel)	Option exercise	+23,920	—	—
Nov 15, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−2,896	$18.01	$52,157
Nov 15, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−4,904	$18.54	$90,920
Nov 15, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−200	$19.28	$3,856
Oct 18, 2023	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−8,000	$13.24	$105,920
Oct 5, 2023	Trevejo Jose M. Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−1,604	$18.00	$28,872

Reviews (0)

No reviews yet. Be the first to write one.